RCMI Coordinating Center (RCMI CC) Header Logo

Guangdi Wang

TitleRCMI Program Director
Faculty RankProfessor
InstitutionXavier University of Louisiana
Departmentchemistry
AddressXavier University of Louisiana
1 Drexel Drive
Chemistry
New Orleans LA 70125
Phone5045205076
vCardDownload vCard

    Collapse Affiliation 

    Collapse Research 
    Collapse research activities and funding
    R03DA017141     (WANG, GUANGDI)Sep 15, 2004 - Jul 31, 2007
    NIH
    RECEPTER BINDING PROPERTIES OF CANNABINOID METABOLITES
    Role: Principal Investigator
    G12MD007595     (D'AMOUR, GENE)Sep 24, 2009 - Mar 31, 2019
    NIH
    Xavier RCMI Center for Cancer Research
    Role: Co-Principal Investigator
    U54MD007595     (D'AMOUR, GENE ;WANG, GUANGDI)Sep 24, 2009 - Dec 31, 2023
    NIH
    Xavier RCMI Renewal Application-Overall
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kang B, Mottamal M, Zhong Q, Bratton M, Zhang C, Guo S, Hossain A, Ma P, Zhang Q, Wang G, Payton-Stewart F. Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer. Pharmaceuticals (Basel). 2023 May 12; 16(5). PMID: 37242518.
      Citations:    
    2. Zheng S, Liu J, Kang B, Wang G. Design and synthesis of a novel ZB716-d6 as a stable isotopically labeled internal standard. Synth Commun. 2022; 52(11-12):1441-1447. PMID: 36420104.
      Citations:    
    3. Liu J, Rajasekaran N, Hossain A, Zhang C, Guo S, Kang B, Jung H, Kim H, Wang G. Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies. Pharmaceuticals (Basel). 2021 Jul 26; 14(8). PMID: 34451816.
      Citations:    
    4. Mottamal M, Kang B, Peng X, Wang G. From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target. ACS Omega. 2021 Apr 13; 6(14):9334-9343. PMID: 33869913.
      Citations:    
    5. Wang G. Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents. Transl Cancer Res. 2020 Aug; 9(8):4464-4468. PMID: 32968620.
      Citations:    
    6. Guo S, Zhang C, Mottamal M, Hossain A, Liu J, Wang G. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020 Apr; 180(2):359-368. PMID: 32030569.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    7. Zhang C, Guo S, Zhong Q, Zhang Q, Hossain A, Zheng S, Wang G. Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability. Pharmaceuticals (Basel). 2019 Dec 08; 12(4). PMID: 31817969.
      Citations:    
    8. Wang G. Cancer Immunotherapy and Immunomodulation. Curr Med Chem. 2019; 26(17):2988-2989. PMID: 31526344.
      Citations: 1     Fields:    Translation:Humans
    9. Zhang Y, Huang Z, Wang L, Wang C, Zhang C, Wiese T, Wang G, Riley K, Wang Z. Point-of-Care Determination of Acetaminophen Levels with Multi-Hydrogen Bond Manipulated Single-Molecule Recognition (eMuHSiR). Anal Chem. 2018 04 03; 90(7):4733-4740. PMID: 29543434.
      Citations: 3     Fields:    Translation:AnimalsCells
    10. Guo S, Zhang C, Bratton M, Mottamal M, Liu J, Ma P, Zheng S, Zhong Q, Yang L, Wiese TE, Wu Y, Ellis MJ, Matossian M, Burow ME, Miele L, Houtman R, Wang G. ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models. Oncotarget. 2018 Jan 23; 9(6):6924-6937. PMID: 29467940.
      Citations: 14     Fields:    
    11. Zheng S, Guo S, Zhong Q, Zhang C, Liu J, Yang L, Zhang Q, Wang G. Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors. ACS Med Chem Lett. 2018 Feb 08; 9(2):149-154. PMID: 29456804.
      Citations:    
    12. Zhang C, Guo S, Yang L, Liu J, Zheng S, Zhong Q, Zhang Q, Wang G. Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD). Oncotarget. 2017 Nov 28; 8(61):103874-103889. PMID: 29262607.
      Citations: 9     Fields:    
    13. Komati R, Spadoni D, Zheng S, Sridhar J, Riley KE, Wang G. Ligands of Therapeutic Utility for the Liver X Receptors. Molecules. 2017 Jan 05; 22(1). PMID: 28067791.
      Citations: 38     Fields:    Translation:HumansCells
    14. Liu J, Zheng S, Guo S, Zhang C, Zhong Q, Zhang Q, Ma P, Skripnikova EV, Bratton MR, Wiese TE, Wang G. Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator. ACS Med Chem Lett. 2017 Jan 12; 8(1):102-106. PMID: 28105283.
      Citations:    
    15. Liu Z, Huang Z, Cheng F, Guo Z, Wang G, Chen X, Wang Z. Efficient Dual-Site Carbon Monoxide Electro-Catalysts via Interfacial Nano-Engineering. Sci Rep. 2016 09 21; 6:33127. PMID: 27650532.
      Citations: 3     Fields:    Translation:Cells
    16. Liu J, Zheng S, Akerstrom VL, Yuan C, Ma Y, Zhong Q, Zhang C, Zhang Q, Guo S, Ma P, Skripnikova EV, Bratton MR, Pannuti A, Miele L, Wiese TE, Wang G. Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD). J Med Chem. 2016 09 08; 59(17):8134-40. PMID: 27529700.
      Citations: 25     Fields:    Translation:AnimalsCells
    17. Du F, Li Y, Zhang W, Kale SP, McFerrin H, Davenport I, Wang G, Skripnikova E, Li XL, Bowen NJ, McDaniels LB, Meng YX, Polk P, Liu YY, Zhang QJ. Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression. Tumour Biol. 2016 Aug; 37(8):11147-11162. PMID: 26935058.
      Citations: 6     Fields:    Translation:AnimalsCells
    18. Zheng S, Liu J, Wu Y, Huang TL, Wang G. Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics. Future Med Chem. 2015; 7(18):2485-505. PMID: 26670195.
      Citations: 8     Fields:    Translation:HumansCells
    19. Zhong Q, Zhang C, Zhang Q, Miele L, Zheng S, Wang G. Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status. BMC Cancer. 2015 Sep 09; 15:625. PMID: 26354796.
      Citations: 14     Fields:    Translation:AnimalsCells
    20. Liu J, Pham PT, Skripnikova EV, Zheng S, Lovings LJ, Wang Y, Goyal N, Bellow SM, Mensah LM, Chatters AJ, Bratton MR, Wiese TE, Zhao M, Wang G, Foroozesh M. A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2. J Med Chem. 2015 Aug 27; 58(16):6481-93. PMID: 26222195.
      Citations: 9     Fields:    Translation:HumansCells
    21. Zhao LM, Ma FY, Jin HS, Zheng S, Zhong Q, Wang G. Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach. Eur J Med Chem. 2015 Sep 18; 102:303-9. PMID: 26291039.
      Citations: 2     Fields:    Translation:HumansCells
    22. Zhang C, Zhong Q, Zhang Q, Zheng S, Miele L, Wang G. Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer. Breast Cancer Res Treat. 2015 Jul; 152(2):283-91. PMID: 26071758.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    23. Wang R, Chen C, Zhang X, Zhang C, Zhong Q, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents. J Med Chem. 2015 Jun 11; 58(11):4713-26. PMID: 25961334.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    24. Washington C, Maxwell J, Stevenson J, Malone G, Lowe EW, Zhang Q, Wang G, McIntyre NR. Mechanistic studies of the tyrosinase-catalyzed oxidative cyclocondensation of 2-aminophenol to 2-aminophenoxazin-3-one. Arch Biochem Biophys. 2015 Jul; 577-578:24-34. PMID: 25982123.
      Citations: 5     Fields:    Translation:AnimalsCells
    25. Mottamal M, Zheng S, Huang TL, Wang G. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Molecules. 2015 Mar 02; 20(3):3898-941. PMID: 25738536.
      Citations: 247     Fields:    Translation:HumansAnimals
    26. Xiong P, Wang R, Zhang X, DeLa Torre E, Leon F, Zhang Q, Zheng S, Wang G, Chen QH. Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents. Anticancer Agents Med Chem. 2015; 15(9):1197-203. PMID: 25991428.
      Citations: 8     Fields:    Translation:HumansCells
    27. Parajuli KR, Zhang Q, Liu S, Patel NK, Lu H, Zeng SX, Wang G, Zhang C, You Z. Methoxyacetic acid suppresses prostate cancer cell growth by inducing growth arrest and apoptosis. Am J Clin Exp Urol. 2014; 2(4):300-12. PMID: 25606576.
      Citations:    
    28. Strong AL, Ohlstein JF, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Gimble JM, Burow ME, Wang G, Bunnell BA. Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms. Stem Cell Res Ther. 2014 Aug 28; 5(4):105. PMID: 25168698.
      Citations: 8     Fields:    Translation:HumansCells
    29. Zheng S, Zhong Q, Xi Y, Mottamal M, Zhang Q, Schroeder RL, Sridhar J, He L, McFerrin H, Wang G. Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion. J Med Chem. 2014 Aug 14; 57(15):6653-67. PMID: 25007006.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    30. Zheng S, Zhong Q, Mottamal M, Zhang Q, Zhang C, Lemelle E, McFerrin H, Wang G. Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents. J Med Chem. 2014 Apr 24; 57(8):3369-81. PMID: 24669888.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    31. Scarritt ME, Bonvillain RW, Burkett BJ, Wang G, Glotser EY, Zhang Q, Sammarco MC, Betancourt AM, Sullivan DE, Bunnell BA. Hypertensive rat lungs retain hallmarks of vascular disease upon decellularization but support the growth of mesenchymal stem cells. Tissue Eng Part A. 2014 May; 20(9-10):1426-43. PMID: 24378017.
      Citations: 12     Fields:    Translation:AnimalsCells
    32. Samaan N, Zhong Q, Fernandez J, Chen G, Hussain AM, Zheng S, Wang G, Chen QH. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents. Eur J Med Chem. 2014 Mar 21; 75:123-31. PMID: 24531225.
      Citations: 18     Fields:    Translation:HumansCells
    33. Strong AL, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Burow ME, Bunnell BA, Wang G. Design, synthesis, and osteogenic activity of daidzein analogs on human mesenchymal stem cells. ACS Med Chem Lett. 2014 Feb 13; 5(2):143-8. PMID: 24900787.
      Citations:    
    34. Zhou W, Wang G, Guo S. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2013 Dec; 1836(2):304-20. PMID: 24183943.
      Citations: 26     Fields:    Translation:HumansAnimalsCells
    35. Guo S, Zou J, Wang G. Advances in the proteomic discovery of novel therapeutic targets in cancer. Drug Des Devel Ther. 2013; 7:1259-71. PMID: 24187485.
      Citations: 9     Fields:    Translation:HumansCells
    36. Kode NR, Vanden Eynde JJ, Mayence A, Wang G, Huang TL. Design and synthesis of N?,N5-bis[4-(5-alkyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramides as potential antifungal prodrugs. Molecules. 2013 Sep 12; 18(9):11250-63. PMID: 24036514.
      Citations: 2     Fields:    Translation:AnimalsCells
    37. Rider MA, Zou J, Vanlandingham D, Nuckols JT, Higgs S, Zhang Q, Lacey M, Kim J, Wang G, Hong YS. Quantitative proteomic analysis of the Anopheles gambiae (Diptera: Culicidae) midgut infected with o'nyong-nyong virus. J Med Entomol. 2013 Sep; 50(5):1077-88. PMID: 24180113.
      Citations: 9     Fields:    Translation:AnimalsCells
    38. Jiang Q, Zheng S, Wang G. Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer. Future Med Chem. 2013 Jun; 5(9):1023-35. PMID: 23734685.
      Citations: 10     Fields:    Translation:Humans
    39. Tilghman SL, Townley I, Zhong Q, Carriere PP, Zou J, Llopis SD, Preyan LC, Williams CC, Skripnikova E, Bratton MR, Zhang Q, Wang G. Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness. Mol Cell Proteomics. 2013 Sep; 12(9):2440-55. PMID: 23704778.
      Citations: 38     Fields:    Translation:HumansCells
    40. Patel AR, Chougule MB, I T, Patlolla R, Wang G, Singh M. Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel. Pharm Res. 2013 May; 30(5):1435-46. PMID: 23361589.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    41. Zheng S, Zhong Q, Jiang Q, Mottamal M, Zhang Q, Zhu N, Burow ME, Worthylake RA, Wang G. Discovery of a Series of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion. ACS Med Chem Lett. 2013 Feb 14; 4(2):191-196. PMID: 23526571.
      Citations:    
    42. Liu M, Wang G, Gomez-Fernandez CR, Guo S. GREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancer. PLoS One. 2012; 7(10):e46410. PMID: 23056300.
      Citations: 21     Fields:    Translation:HumansCells
    43. Bonvillain RW, Danchuk S, Sullivan DE, Betancourt AM, Semon JA, Eagle ME, Mayeux JP, Gregory AN, Wang G, Townley IK, Borg ZD, Weiss DJ, Bunnell BA. A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells. Tissue Eng Part A. 2012 Dec; 18(23-24):2437-52. PMID: 22764775.
      Citations: 75     Fields:    Translation:AnimalsCells
    44. Abbaraju NV, Boutaghou MN, Townley IK, Zhang Q, Wang G, Cole RB, Rees BB. Analysis of tissue proteomes of the Gulf killifish, Fundulus grandis, by 2D electrophoresis and MALDI-TOF/TOF mass spectrometry. Integr Comp Biol. 2012 Nov; 52(5):626-35. PMID: 22537935.
      Citations: 3     Fields:    Translation:AnimalsCellsPHPublic Health
    45. Jiang Q, Zhong Q, Zhang Q, Zheng S, Wang G. Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast Cancer. ACS Med Chem Lett. 2012 Apr 06; 3(5):392-396. PMID: 23864928.
      Citations:    
    46. Wang G, Ma P, Zhang Q, Lewis J, Lacey M, Furukawa Y, O'Reilly SE, Meaux S, McLachlan J, Zhang S. Endocrine disrupting chemicals in New Orleans surface waters and Mississippi Sound sediments. J Environ Monit. 2012 May; 14(5):1353-64. PMID: 22438038.
      Citations: 7     Fields:    Translation:PHPublic Health
    47. Zhou C, Zhong Q, Rhodes LV, Townley I, Bratton MR, Zhang Q, Martin EC, Elliott S, Collins-Burow BM, Burow ME, Wang G. Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Res. 2012 Mar 14; 14(2):R45. PMID: 22417809.
      Citations: 67     Fields:    Translation:HumansCells
    48. Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2012 Apr; 1825(2):207-22. PMID: 22289780.
      Citations: 71     Fields:    Translation:HumansAnimalsCells
    49. Rhodes LV, Tilghman SL, Boue SM, Wang S, Khalili H, Muir SE, Bratton MR, Zhang Q, Wang G, Burow ME, Collins-Burow BM. Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer. Oncol Lett. 2012 Jan; 3(1):163-171. PMID: 22740874.
      Citations:    
    50. Jiang Q, Payton-Stewart F, Elliott S, Driver J, Rhodes LV, Zhang Q, Zheng S, Bhatnagar D, Boue SM, Collins-Burow BM, Sridhar J, Stevens C, McLachlan JA, Wiese TE, Burow ME, Wang G. Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells. J Med Chem. 2010 Aug 26; 53(16):6153-63. PMID: 20669983.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    51. Zhang Q, Ma P, Cole RB, Wang G. In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes. Eur J Pharm Sci. 2010 Sep 11; 41(1):163-72. PMID: 20542112.
      Citations:    Fields:    Translation:AnimalsCells
    52. Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, Nephew KP, Shan B, Burow ME, Wang G. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res. 2008; 10(6):R105. PMID: 19087274.
      Citations: 62     Fields:    Translation:Humans
    53. Liebl AL, Granados LH, Zhang Q, Wang G, Mielke HW, Gonzales CR, Ennis DG, Rees BB. Effects of post-Hurricane Katrina New Orleans (LA, USA) sediments on early development of the Japanese medaka (Oryzias latipes). Environ Toxicol Chem. 2008 Dec; 27(12):2557-64. PMID: 18620474.
      Citations: 2     Fields:    Translation:Animals
    54. Huang TL, Bacchi CJ, Kode NR, Zhang Q, Wang G, Yartlet N, Rattendi D, Londono I, Mazumder L, Vanden Eynde JJ, Mayence A, Donkor IO. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug. Int J Antimicrob Agents. 2007 Dec; 30(6):555-61. PMID: 17920820.
      Citations: 6     Fields:    Translation:HumansAnimals
    55. Zhang Q, Ma P, Cole RB, Wang G. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Anal Bioanal Chem. 2006 Nov; 386(5):1345-55. PMID: 16955257.
      Citations: 14     Fields:    Translation:Cells
    56. Painter RG, Valentine VG, Lanson NA, Leidal K, Zhang Q, Lombard G, Thompson C, Viswanathan A, Nauseef WM, Wang G, Wang G. CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry. 2006 Aug 29; 45(34):10260-9. PMID: 16922501.
      Citations: 127     Fields:    Translation:HumansCells
    57. Zhang S, Zhang Q, Darisaw S, Ehie O, Wang G. Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi river water, in New Orleans, Louisiana, USA. Chemosphere. 2007 Jan; 66(6):1057-69. PMID: 16884762.
      Citations: 28     Fields:    Translation:PHPublic Health
    58. Wang W, Hua Y, Wang G, Cole RB. Characterization of rat liver microsomal and hepatocytal metabolites of brevetoxins by liquid chromatography-electrospray tandem mass spectrometry. Anal Bioanal Chem. 2005 Sep; 383(1):67-75. PMID: 16059676.
      Citations: 4     Fields:    Translation:AnimalsCells
    59. Zhang Q, Ma P, Wang W, Cole RB, Wang G. In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands. Drug Metab Dispos. 2005 Apr; 33(4):508-17. PMID: 15616153.
      Citations: 3     Fields:    Translation:AnimalsCells
    60. Mielke HW, Wang G, Gonzales CR, Powell ET, Le B, Quach VN. PAHs and metals in the soils of inner-city and suburban New Orleans, Louisiana, USA. Environ Toxicol Pharmacol. 2004 Dec; 18(3):243-7. PMID: 21782755.
      Citations: 25     Fields:    
    61. Zhang Q, Ma P, Wang W, Cole RB, Wang G. Characterization of rat liver microsomal metabolites of AM-630, a potent cannabinoid receptor antagonist, by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. J Mass Spectrom. 2004 Jun; 39(6):672-81. PMID: 15236306.
      Citations: 7     Fields:    Translation:AnimalsCells
    62. Zhang Q, Ma P, Iszard M, Cole RB, Wang W, Wang G. In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist. Drug Metab Dispos. 2002 Oct; 30(10):1077-86. PMID: 12228183.
      Citations: 10     Fields:    Translation:AnimalsCells
    Wang's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (297)
    Explore
    _
    Co-Authors (13)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support